AAAAAA
Results: 1-25/28
Authors:
ACKERMAN DL
GREENLAND S
BYSTRITSKY A
Citation: Dl. Ackerman et al., CLINICAL CHARACTERISTICS OF RESPONSE TO FLUOXETINE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER, Journal of clinical psychopharmacology, 18(3), 1998, pp. 185-192
Authors:
SAXENA S
BYSTRITSKY A
Citation: S. Saxena et A. Bystritsky, RISPERIDONE MAY WORSEN FLUOXETINE-TREATED OCD - REPLY, The Journal of clinical psychiatry, 59(5), 1998, pp. 256-256
Authors:
SCHNEIDER LS
SMALL GW
HAMILTON SH
BYSTRITSKY A
NEMEROFF CB
MEYERS BS
ABUZZAHAB FS
ALEXOPOULOS GS
BIELSKI RJ
BORISON RL
BROD MS
COHENCOLE SA
COHN CK
DOWNS JM
DUPONT RL
FERGUSON JM
FOLKS DG
GOTTLIEB GL
GRABER B
MENOLASCINO FJ
HALARIS AE
HARTFORD JT
HERTZMAN M
JEFFERSON JW
JESTE DV
KORAN LM
LAZARUS LW
NAKRA BRS
OXENKRUG GF
RAPPAPORT SA
ROSENTHAL MH
SALZMAN C
SHRIVASTAVA R
STOKES PE
WINSTON JL
WHEADON DW
SCHATZ EJ
MARVEL DE
ALBRITTON R
TOLLEFSON GD
Citation: Ls. Schneider et al., ESTROGEN REPLACEMENT AND RESPONSE TO FLUOXETINE IN A MULTICENTER GERIATRIC DEPRESSION TRIAL, The American journal of geriatric psychiatry, 5(2), 1997, pp. 97-106
Authors:
SMALL GW
BYSTRITSKY A
Citation: Gw. Small et A. Bystritsky, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 2 DOSES OF ABECARNIL FOR GERIATRIC ANXIETY, The Journal of clinical psychiatry, 58, 1997, pp. 24-29
Authors:
ACKERMAN DL
GREENLAND S
BYSTRITSKY A
SMALL GW
Citation: Dl. Ackerman et al., CHARACTERISTICS OF FLUOXETINE VERSUS PLACEBO RESPONDERS IN A RANDOMIZED TRIAL OF GERIATRIC DEPRESSION, Psychopharmacology bulletin, 33(4), 1997, pp. 707-714
Authors:
ACKERMAN DL
GREENLAND S
SMALL GW
BYSTRITSKY A
Citation: Dl. Ackerman et al., CHARACTERISTICS OF FLUOXETINE VS. PLACEBO RESPONDERS IN A RANDOMIZED TRIAL OF GERIATRIC DEPRESSION, Psychopharmacology bulletin, 33(3), 1997, pp. 485-485
Authors:
BYSTRITSKY A
Citation: A. Bystritsky, EEG ABNORMALITIES IN NONMEDICATED PANIC DISORDER, Psychopharmacology bulletin, 33(3), 1997, pp. 500-500
Authors:
ACKERMAN DL
GREENLAND S
SMALL GW
BYSTRITSKY A
Citation: Dl. Ackerman et al., CHARACTERISTICS OF FLUOXETINE VS PLACEBO RESPONDERS IN A RANDOMIZED TRIAL OF GERIATRIC DEPRESSION, American journal of epidemiology, 145(11), 1997, pp. 147-147
Authors:
BYSTRITSKY A
MUNFORD PR
ROSEN RM
MARTIN KM
VAPNIK T
GORBIS EE
WOLSON RC
Citation: A. Bystritsky et al., A PRELIMINARY-STUDY OF PARTIAL HOSPITAL MANAGEMENT OF SEVERE OBSESSIVE-COMPULSIVE DISORDER, Psychiatric services, 47(2), 1996, pp. 170-174
Authors:
BYSTRITSKY A
WAIKAR SV
VAPNIK T
Citation: A. Bystritsky et al., 4-DIMENSIONAL ANXIETY AND DEPRESSION SCALE - A PRELIMINARY PSYCHOMETRIC REPORT, Anxiety, 2(1), 1996, pp. 47-50
Authors:
MAIDENBERG E
CHEN E
CRASKE M
BOHN P
BYSTRITSKY A
Citation: E. Maidenberg et al., SPECIFICITY OF ATTENTIONAL BIAS IN PANIC DISORDER AND SOCIAL PHOBIA, Journal of anxiety disorders, 10(6), 1996, pp. 529-541
Authors:
SMALL GW
SCHNEIDER LS
HAMILTON SH
BYSTRITSKY A
MEYERS BS
NEMEROFF CB
Citation: Gw. Small et al., SITE VARIABILITY IN A MULTISITE GERIATRIC DEPRESSION TRIAL, International journal of geriatric psychiatry, 11(12), 1996, pp. 1089-1095
Authors:
ACKERMAN DL
GREENLAND S
BYSTRITSKY A
KATZ RJ
Citation: Dl. Ackerman et al., RELATIONSHIP BETWEEN EARLY SIDE-EFFECTS AND THERAPEUTIC EFFECTS OF CLOMIPRAMINE THERAPY IN OBSESSIVE-COMPULSIVE DISORDER, Journal of clinical psychopharmacology, 16(4), 1996, pp. 324-328
Authors:
BYSTRITSKY A
STRAUSSER BP
Citation: A. Bystritsky et Bp. Strausser, TREATMENT OF OBSESSIVE-COMPULSIVE CUTTING BEHAVIOR WITH NALTREXONE, The Journal of clinical psychiatry, 57(9), 1996, pp. 423-424
Authors:
SAXENA S
WANG D
BYSTRITSKY A
BAXTER LR
Citation: S. Saxena et al., RISPERIDONE AUGMENTATION OF SRI TREATMENT FOR REFRACTORY OBSESSIVE-COMPULSIVE DISORDER, The Journal of clinical psychiatry, 57(7), 1996, pp. 303-306
Authors:
ACKERMAN DL
GREENLAND S
BYSTRITSKY A
Citation: Dl. Ackerman et al., USE OF RECEIVER-OPERATOR CHARACTERISTIC (ROC) CURVE ANALYSIS TO EVALUATE PREDICTORS OF RESPONSE TO CLOMIPRAMINE THERAPY, Psychopharmacology bulletin, 32(1), 1996, pp. 157-165
Authors:
SMALL GW
BIRKETT M
MEYERS BS
KORAN LM
BYSTRITSKY A
NEMEROFF CB
ABUZZAHAB FS
ALEXOPOULOS GS
BIELSKI RJ
BORISON RL
BROD MS
COHENCOLE SA
COHN CK
DOWNS JM
DUPONT RL
FERGUSON JM
FOLKS DG
GOTTLIEB GL
GRABER B
MENOLASCINO FJ
HALARIS AE
HARTFORD JT
HERTZMAN M
JEFFERSON JW
JESTE DV
LAZARUS LW
NAKRA BR
OXENKRUG GF
RAPPAPORT SA
ROSENTHAL MH
SALZMAN C
SHRIVASTAVA RK
STOKES PE
WINSTON JL
WHEADON DW
SCHATZ EJ
MARVEL DE
ALBRITTON R
TOLLEFSON GD
LILLY E
Citation: Gw. Small et al., IMPACT OF PHYSICAL ILLNESS ON QUALITY-OF-LIFE AND ANTIDEPRESSANT RESPONSE IN GERIATRIC MAJOR DEPRESSION, Journal of the American Geriatrics Society, 44(10), 1996, pp. 1220-1225
Authors:
STOESSEL PW
BYSTRITSKY A
PASNAU RO
Citation: Pw. Stoessel et al., SCREENING FOR ANXIETY DISORDERS IN THE PRIMARY-CARE SEATING, Family practice, 12(4), 1995, pp. 448-451
Authors:
BYSTRITSKY A
CRASKE M
MAIDENBERG E
VAPNIK T
SHAPIRO D
Citation: A. Bystritsky et al., AMBULATORY MONITORING OF PANIC PATIENTS DURING REGULAR ACTIVITY - A PRELIMINARY-REPORT, Biological psychiatry, 38(10), 1995, pp. 684-689
Authors:
CRASKE MG
MAIDENBERG E
BYSTRITSKY A
Citation: Mg. Craske et al., BRIEF COGNITIVE-BEHAVIORAL VERSUS NONDIRECTIVE THERAPY FOR PANIC DISORDER, Journal of behavior therapy and experimental psychiatry, 26(2), 1995, pp. 113-120
Authors:
BYSTRITSKY A
ROSEN RM
MURPHY KJ
BOHN P
KEYS SA
VAPNIK T
Citation: A. Bystritsky et al., DOUBLE-BLIND PILOT TRIAL OF DESIPRAMINE VERSUS FLUOXETINE IN PANIC PATIENTS, Anxiety, 1(6), 1994, pp. 287-290
Authors:
WAIKAR SV
BYSTRITSKY A
CRASKE MG
MURPHY K
Citation: Sv. Waikar et al., ETIOLOGIC BELIEFS AND TREATMENT PREFERENCES IN ANXIETY-DISORDERED PATIENTS, Anxiety, 1(3), 1994, pp. 134-137
Authors:
ACKERMAN DL
GREENLAND S
BYSTRITSKY A
MORGENSTERN H
KATZ RJ
Citation: Dl. Ackerman et al., PREDICTORS OF TREATMENT RESPONSE IN OBSESSIVE-COMPULSIVE DISORDER - MULTIVARIATE ANALYSES FROM A MULTICENTER TRIAL OF CLOMIPRAMINE, Journal of clinical psychopharmacology, 14(4), 1994, pp. 247-254
Authors:
TARG EF
KARASIC DH
DIEFENBACH PN
ANDERSON DA
BYSTRITSKY A
FAWZY FI
Citation: Ef. Targ et al., STRUCTURED GROUP-THERAPY AND FLUOXETINE TO TREAT DEPRESSION IN HIV-POSITIVE PERSONS, Psychosomatics, 35(2), 1994, pp. 132-137
Authors:
BYSTRITSKY A
WAIKAR SV
Citation: A. Bystritsky et Sv. Waikar, INERT PLACEBO VERSUS ACTIVE MEDICATION - PATIENT BLINDABILITY IN CLINICAL PHARMACOLOGICAL TRIALS, The Journal of nervous and mental disease, 182(9), 1994, pp. 485-487